Literature DB >> 27826752

Essential role of interferon regulatory factor 4 (IRF4) in immune cell development.

Sorim Nam1, Jong-Seok Lim2.   

Abstract

The family of interferon regulatory factors, which includes nine mammalian members (IRF1-IRF9), acts as transcription factors for interferons and thus exerts regulatory functions in the immune system and in oncogenesis. Among these members, IRF4 expression is restricted to immune cells such as T and B lymphocytes, macrophages, and dendritic cells where it is a key factor in the regulation of differentiation and is required during the immune response for lymphocyte activation and the generation of immunoglobulin-secreting plasma cells. Consequently, dysregulation of IRF4 is associated with many lymphoid malignancies. Recent studies have demonstrated that depending on the context and stage of hematopoietic cell differentiation in which its expression is dysregulated, IRF4 may act as either an oncogene or a tumor-suppressor-like factor. In addition, it has been shown that IRF4 plays a pivotal role in the development and function of several autoimmune-associated cells. Various genetic and functional studies have also pointed to IRF4 as a master regulator for autoimmunity. In this review, the roles of IRF4 in the immune response are briefly summarized and discussed, with particular focus on its essential and distinct functions in immune cell development.

Entities:  

Keywords:  Dendritic cells (DCs); Interferon regulatory factor 4 (IRF4); Lymphoid cells; Macrophages; Myeloid cells; Myeloid-derived suppressor cells (MDSCs)

Mesh:

Substances:

Year:  2016        PMID: 27826752     DOI: 10.1007/s12272-016-0854-1

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  32 in total

1.  B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Authors:  Daniela Asslaber; Yuan Qi; Nicole Maeding; Markus Steiner; Ursula Denk; Jan Philip Höpner; Tanja Nicole Hartmann; Nadja Zaborsky; Richard Greil; Alexander Egle
Journal:  Blood       Date:  2019-11-14       Impact factor: 22.113

2.  Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy.

Authors:  Ming Li; Ling Wang; Dian-Chun Shi; Jia-Nee Foo; Zhong Zhong; Chiea-Chuen Khor; Chiara Lanzani; Lorena Citterio; Erika Salvi; Pei-Ran Yin; Jin-Xin Bei; Li Wang; Yun-Hua Liao; Jian Chen; Qin-Kai Chen; Gang Xu; Geng-Ru Jiang; Jian-Xin Wan; Meng-Hua Chen; Nan Chen; Hong Zhang; Yi-Xin Zeng; Zhi-Hong Liu; Jian-Jun Liu; Xue-Qing Yu
Journal:  J Am Soc Nephrol       Date:  2020-09-10       Impact factor: 10.121

3.  Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscape.

Authors:  Lingli Huang; Xin Liu; Li Li; Lei Wang; Nan Wu; Zhixian Liu
Journal:  Med Oncol       Date:  2022-05-15       Impact factor: 3.064

4.  The molecular basis for the development of adult T-cell leukemia/lymphoma in patients with an IRF4K59R mutation.

Authors:  Srinivasan Sundararaj; Sandali Seneviratne; Simon J Williams; Anselm Enders; Marco G Casarotto
Journal:  Protein Sci       Date:  2022-02-15       Impact factor: 6.725

Review 5.  Acetyl-CoA Synthetase 2 as a Therapeutic Target in Tumor Metabolism.

Authors:  Mengfang Liu; Na Liu; Jinlei Wang; Shengqiao Fu; Xu Wang; Deyu Chen
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

6.  Distinct cell-types in the prostate share an aging signature suggestive of metabolic reprogramming.

Authors:  Preston D Crowell; Jenna M Giafaglione; Takao Hashimoto; Andrew S Goldstein
Journal:  Am J Clin Exp Urol       Date:  2020-08-15

7.  Genome-Wide Identification, Comparison, and Expression Analysis of Transcription Factors in Ascidian Styela clava.

Authors:  Jin Zhang; Jiankai Wei; Haiyan Yu; Bo Dong
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

8.  Blood Transcriptomics of Turbot Scophthalmus maximus: A Tool for Health Monitoring and Disease Studies.

Authors:  Paolo Ronza; José Antonio Álvarez-Dios; Diego Robledo; Ana Paula Losada; Roberto Romero; Roberto Bermúdez; Belén G Pardo; Paulino Martínez; María Isabel Quiroga
Journal:  Animals (Basel)       Date:  2021-04-30       Impact factor: 2.752

9.  Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.

Authors:  Xuanzong Li; Shujun Zhai; Jianbo Zhang; Dai Zhang; Shijiang Wang; Linlin Wang; Jinming Yu
Journal:  Front Oncol       Date:  2021-06-14       Impact factor: 6.244

10.  IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia.

Authors:  Xiao Huang; Tingting Ma; Yongmei Zhu; Bo Jiao; Shanhe Yu; Kankan Wang; Jian-Qing Mi; Ruibao Ren
Journal:  Front Med       Date:  2021-07-31       Impact factor: 9.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.